Ovarian, Fallopian Tube, and Peritoneal Cancer: Risk Factors and Prevention

Approved by the Cancer.Net Editorial Board, 04/2019

ON THIS PAGE: You will find out more about the factors that increase the chance of developing ovarian, fallopian tube, and peritoneal cancer. Use the menu to see other pages.

A risk factor is anything that increases a person's chance of developing cancer. Although risk factors often influence the development of cancer, most do not directly cause cancer. Some people with several risk factors never develop cancer, while others with no known risk factors do. Knowing your risk factors and talking about them with your doctor may help you make more informed lifestyle and health care choices.

The following factors may raise a woman's risk of developing ovarian/fallopian tube cancer.

  • Family history. A strong family history of breast or ovarian/fallopian tube cancer puts women at higher risk for ovarian/fallopian tube cancer. Doctors believe this is because many of these families have genetic mutations (changes in the gene) that are passed from generation to generation (see “Genetics,” below). If you are concerned that ovarian/fallopian tube cancer may run in your family, it is important to get an accurate family history, including breast cancers in the family. By understanding your family history, you and your doctor can talk about ways to reduce your risk and be proactive about your health.

  • Genetics. About 10% to 15% of ovarian/fallopian tube cancers occur because a genetic mutation, or change, has been passed down within a family. All women with ovarian/fallopian tube cancer who are younger than 70 should receive genetic testing for the BRCA1 and BRCA2 mutation, regardless of whether there is a family history of ovarian or breast cancer. Women may also want to be tested for the genes related to Lynch syndrome (see below) and other cancer risk genes, based on their type of ovarian/fallopian tube cancer.

    A mutation in the BRCA1 or BRCA2 gene is associated with an increased risk of developing these cancers. A woman with an "average risk" has only a 1% to 2% lifetime risk of developing ovarian/fallopian tube cancer. A woman with a BRCA1 mutation has around a 40% lifetime risk, and a woman with a BRCA2 mutation has about a 10% to 20% lifetime risk. While less common, BRCA-related ovarian/fallopian tube cancers can occur in women who do not have a family history of either breast or ovarian/fallopian tube cancer. About 40% of women with ovarian/fallopian tube cancer who are found to have a BRCA mutation do not have a family history. Because of this, genetic testing for other family members may be recommended if a person has a BRCA mutation, because these cancers can be inherited. Read more about the BRCA1 and BRCA2 genes in this website’s section on hereditary breast and ovarian cancer.

  • Genetic conditions. There are several other genetic conditions that cause ovarian/fallopian tube cancer. Some of the most common include:

    • Lynch syndrome. Lynch syndrome, also known as hereditary non-polyposis colorectal cancer, increases a woman's risk of ovarian/fallopian tube cancer and uterine cancer. It is caused by mutations in several different genes. Lynch syndrome also increases the risk of colorectal cancer and several other cancers.

    • Peutz-Jeghers syndrome (PJS). PJS is caused by a specific genetic mutation. The syndrome is associated with multiple polyps in the digestive tract that become noncancerous tumors and with increased pigmentation (dark spots on the skin) on the face and hands. PJS raises the risk of ovarian/fallopian tube cancer, breast cancer, colorectal cancer, cervical cancer, and several other types of cancer.

    • Nevoid basal cell carcinoma syndrome (NBCCS). Women with NBCCS, also called Gorlin syndrome, have an increased risk of developing fibromas. Fibromas are benign fibrous tumors of the ovaries. There is a small risk that these fibromas could develop into a type of ovarian cancer called fibrosarcoma. People with NBCCS often have multiple basal cell skin cancers and jaw cysts and may develop medulloblastoma, a type of brain tumor, in childhood.

    • Li-Fraumeni syndrome and ataxia-telangiectasia. Women with Li-Fraumeni syndrome or ataxia-telangiectasia may have a slightly increased risk of developing ovarian cancer.

      There may be other hereditary syndromes linked to these types of cancer, and research in this area is ongoing. Only genetic testing can determine whether a person has a genetic mutation. Most experts strongly recommend that people who are considering genetic testing first talk with a genetic counselor. This expert is trained to explain the risks and benefits of genetic testing.

  • Age. A woman’s risk of developing ovarian/fallopian tube cancer increases with age. Women of all ages have a risk of these cancers, but women over 50 are more likely to develop these cancers. About half of the women diagnosed with ovarian/fallopian tube cancer are 63 years or older.

  • Weight. Recent studies show that women who were obese in early adulthood may have an increased risk to develop ovarian/fallopian tube cancer. Women who are obese are more likely to die from any condition, including ovarian/fallopian tube cancer.

  • Endometriosis. When the inside lining of a woman’s uterus grows outside of the uterus, affecting other nearby organs, it is called endometriosis. This condition can cause several problems, but effective treatment is available. Researchers are continuing to study whether endometriosis is a risk factor for ovarian cancer. It may increase the risk of certain types of ovarian cancer, including clear cell and endometrioid ovarian cancers.

  • Ethnicity. Women of North American, Northern European, or Ashkenazi Jewish heritage have an increased risk of ovarian cancer. People of some of these ethnicities have higher risks of BRCA mutations.

  • Reproductive history. Women who started menstruating early in life, have never given birth to a child, have unexplained infertility (the inability to have a child), have not taken birth control pills, or who entered menopause later may have an increased risk of ovarian/fallopian tube cancer.

  • Hormone replacement therapy. Women who have taken estrogen-only hormone replacement therapy (HRT) after menopause may have a higher risk of ovarian/fallopian tube cancer. The risk becomes higher the longer a woman uses the therapy. The risk decreases over time after the therapy ends.

Fertility drugs were once thought to increase the risk of ovarian/fallopian tube cancer. It has been shown that they do not increase the risk.


Different factors cause different types of cancer. Researchers continue to study what factors cause these types of cancer, including ways to prevent it. Although there is no proven way to prevent these diseases completely, you may be able to lower your risk. Talk with your health care team for more information about your personal risk of cancer.

Research has shown that certain factors may reduce a woman's risk of developing ovarian/fallopian tube cancer:

  • Taking birth control pills. Women who took oral contraceptives for 3 or more years are 30% to 50% less likely to develop ovarian/fallopian tube cancer. The decrease in risk may last for 30 years after a woman stops taking the pills.

  • Breastfeeding. The longer a woman breastfeeds, the lower her risk of developing ovarian/fallopian tube cancer.

  • Pregnancy. The more full-term pregnancies a woman has had, the lower her risk of ovarian/fallopian tube cancer.

  • Surgical procedures. Women who have had a hysterectomy or a tubal ligation may have a lower risk of developing ovarian/fallopian tube cancer. A hysterectomy is the removal of the uterus and, sometimes, the cervix. Tubal ligation is having the fallopian tubes “tied” or closed surgically to prevent pregnancy. Doctors recommend a bilateral salpingo-oophorectomy, which is the removal of both ovaries and fallopian tubes, for women with a high risk of ovarian/fallopian tube cancer. After a woman has given birth to all of the children she intends to have, she may choose to have her fallopian tubes removed at the time of abdominal surgery for other purposes or during a caesarean section, also called a c-section.

    For women with high-risk genetic mutations such as BRCA1, BRCA2, and the genes related to Lynch syndrome, having the ovaries and fallopian tubes removed after having children is recommended to prevent ovarian/fallopian tube cancers as well as possibly reduce the risk of breast cancer. This can reduce ovarian/fallopian tube cancer risk by as much as 96%. If performed before menopause occurs naturally, there may be a 40% to 70% reduction in the risk of developing breast cancer, particularly in women with BRCA2 mutations.

    It is very important for women who are considering preventive surgery to talk with their doctors and genetic counselors so they can understand the risks and side effects of the surgery compared to their personal risk of developing ovarian/fallopian tube cancer.

The next section in this guide is Symptoms and Signs. It explains what body changes or medical problems ovarian, fallopian tube, and peritoneal cancer can cause. Use the menu to choose a different section to read in this guide.